Animal Health Market Growth, Size, Trends Analysis - By Product, By Animal Type, By Distribution Channel, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Animal Health Market Introduction and Overview

According to SPER market research, 'Animal Health Market Size- By Product, By Animal Type, By Distribution Channel, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Animal Health Market is predicted to reach 174.43 billion by 2034 with a CAGR of 10.74%.

Animal health is animals' overall physical and physiological well-being, including their absence of illnesses, infections, and malnutrition, is referred to as animal health. In order to increase longevity and productivity, it includes veterinarian care, healthy eating and hygiene, vaccinations, and illness control. Economic stability, public health, and food safety are all directly impacted by the health of cattle, companion animals, and wildlife.

Restraints: One of the many challenges facing the animal health industry is the high expense of veterinarian care, which restricts access to high-quality care. Product development and commercial entrance are slowed down by stringent regulatory approvals for new medications and vaccines. Diseases that are developing and emerging necessitate ongoing research, which raises R&D costs. In undeveloped nations, low veterinary infrastructure and little knowledge impede market expansion.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Animal Type, By Distribution Channel, By End User.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered Zoetis, Ceva SantA(C) Animale, Merck & Co., Inc., Vetoquinol S.A., Boehringer Ingelheim GmbH, Elanco, Virbac, Mars Inc., Dechra Pharmaceuticals plc, IDEXX Laboratories, Inc.

Animal Health Market Segmentation:

By Product: Based on the Product, Global Animal Health Market is segmented as; Biologics, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Equipment & Disposables, Others.

By Animal Type: Based on the Animal Type, Global Animal Health Market is segmented as; Production Animals, Companion Animals.

By Distribution Channel: Based on the Distribution Channel, Global Animal Health Market is segmented as; Retail, E-Commerce, Hospital/ Clinic Pharmacy.

By End User: Based on the End User, Global Animal Health Market is segmented as; Veterinary Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Product Code: HLCA2595

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Animal Health Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Animal Health Market

7. Global Animal Health Market, By Product 2021-2034 (USD Million)

7.1. Biologics
- 7.1.1. Vaccines
- 7.1.2. Other Biologics
7.2. Pharmaceuticals
- 7.2.1. Parasiticides
- 7.2.2. Anti-infectives
- 7.2.3. Anti-inflammatory
- 7.2.4. Analgesics
- 7.2.5. Others
7.3. Medicinal Feed Additives
7.4. Diagnostics
- 7.4.1. Consumables, reagents and kits
- 7.4.2. Instruments and devices
7.5. Equipment & Disposables
- 7.5.1. Critical Care Consumables
- 7.5.2. Anesthesia Equipment
- 7.5.3. Fluid Management Equipment
- 7.5.4. Temperature Management Equipment
- 7.5.5. Rescue & Resuscitation Equipment
- 7.5.6. Research Equipment
- 7.5.7. Patient Monitoring Equipment
7.6. Others
- 7.6.1. Veterinary Telehealth
- 7.6.2. Veterinary Software
- 7.6.3. Livestock Monitoring

8. Global Animal Health Market, By Animal Type 2021-2034 (USD Million)

8.1. Production Animals
- 8.1.1. Poultry
- 8.1.2. Swine
- 8.1.3. Cattle
- 8.1.4. Sheep & Goats
- 8.1.5. Fish
8.2. Companion Animals
- 8.2.1. Dogs
- 8.2.2. Cats
- 8.2.3. Horses
- 8.2.4. Others

9. Global Animal Health Market, By Distribution Channel 2021-2034 (USD Million)

9.1. Retail
9.2. E-Commerce
9.3. Hospital/ Clinic Pharmacy

10. Global Animal Health Market, By End User 2021-2034 (USD Million)

10.1. Veterinary Reference Laboratories
10.2. Point-of-care Testing/In-house Testing
10.3. Veterinary Hospitals & Clinics
10.4. Others

11. Global Animal Health Market, 2021-2034 (USD Million)

11.1. Global Animal Health Market Size and Market Share

12. Global Animal Health Market, By Region, 2021-2034 (USD Million)

12.1. Asia-Pacific
- 12.1.1. Australia
- 12.1.2. China
- 12.1.3. India
- 12.1.4. Japan
- 12.1.5. South Korea
- 12.1.6. Rest of Asia-Pacific
12.2. Europe
- 12.2.1. France
- 12.2.2. Germany
- 12.2.3. Italy
- 12.2.4. Spain
- 12.2.5. United Kingdom
- 12.2.6. Rest of Europe
12.3. Middle East and Africa
- 12.3.1. Kingdom of Saudi Arabia
- 12.3.2. United Arab Emirates
- 12.3.3. Qatar
- 12.3.4. South Africa
- 12.3.5. Egypt
- 12.3.6. Morocco
- 12.3.7. Nigeria
- 12.3.8. Rest of Middle-East and Africa
12.4. North America
- 12.4.1. Canada
- 12.4.2. Mexico
- 12.4.3. United States
12.5. Latin America
- 12.5.1. Argentina
- 12.5.2. Brazil
- 12.5.3. Rest of Latin America

13. Company Profile

13.1. Boehringer Ingelheim Gmbh
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
13.2. Ceva SantA(C) Animale
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
13.3. Dechra Pharmaceuticals Plc
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
13.4. Elanco
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
13.5. Idexx Laboratories, Inc.
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
13.6. Mars Inc.
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
13.7. Merck & Co., Inc.
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
13.8. Vetoquinol S.A.
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
13.9. Virbac
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
13.10. Zoetis
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
13.11. Others